In its annual report on April 18, 2024, the number of shareholders of the company as of March 31, 2024 was 9,628, a decrease of 987 or 9.30% from the previous period (December 31, 2023).
The number of shareholders is lower than the industry average. According to Choice data, as of March 31, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 34,400. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 30.08%, and Dorui Pharmaceutical is also in the range.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since March 31, 2023, the number of shareholders of the company has decreased significantly, with a decrease of 12.18%. From March 31, 2023 to March 31, 2024, the stock price decreased by 20.34%.
Number of shareholders and share price
Number of shareholders and share capital
As of March 31, 2024, the company's latest total share capital is 80 million shares, of which the outstanding share capital is 27.4237 million shares. The average number of outstanding shares held by households increased from 2,583 shares in the previous period to 2,848 shares, and the average market value of households was 59,400 yuan.
The average amount of shares held by each household
The market value of the circulating market held by Dorui Pharmaceutical is lower than the industry average. According to Choice data, as of March 31, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry was 412,800 yuan. Among them, 24.90% of the company's households hold a circulating stock market value in the range of 140,000~270,000.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.